Skip to main content
. 2017 Mar 21;7:33. doi: 10.1186/s13613-017-0249-6

Table 1.

Studies included in the meta-analysis and major outcome events

Study Number of cirrhotics Period of inclusion Mortality in ICU
N (%)
Mortality in hospital
N (%)
Mortality at 3 months
N (%)
Mortality at 6 months
N (%)
Transplanted at 3 months N (%)/6 months N (%) Study design Specificity of studied population
Jenq [37, 38] 188 2005–2006 95 (50.5) 137 (72.8) 154 (81.9) 157 (83.5) 0 (0.0)/0 (0.0) Prospective
Fichet [10] 71 1995–2005 25 (35.2) 28 (39.4) NA NA 0 (0.0)/0 (0.0) Retrospective 100% stage III/IV HEa
Filloux [36] 83 2002–2006 29 (34.9) 39 (46.9) NA 47 (56.6) NA Retrospective
Karvellas [39] 178 2003–2005 NA 91 (51.1) NA NA NA Retrospective
Das [8] 138 2005–2008 57 (41.3) 75 (54.3) NA NA NA Retrospective
Galbois [6] 56 1995–1998 22 (39.2) 25 (44.6) NA NA NA Retrospective
Levesque [2, 3] 451 2005–2011 17 (38.8) 208 (46.2) 189 (76.8) 211 (85.7) 27 (5.9)/28 (6.2) (2) Prospective/(3) retrospective (2) 0% PO
(3) 100% IMV
Cavallazzi [35] 441 2003–2009 NA 213 (48.3) NA NA 15 (3.4)/15 (3.4) Retrospective
Shawcross [40] 563 2000–2007 256 (45.5) 334 (59.3) NA NA NA Prospective
Sauneuf [5] 89 1997–2010 64 (71.9) 74 (83.1) 77 (86.5) 77 (86.5) 0 (0.0)/2 (2.2) Retrospective 100% septic shock
Theocharidou [7] 265 2005–2012 91 (34.3) 125 (47.1) 168 (63.3) 173 (65.2) NA Retrospective

NA not available, HE hepatic encephalopathy, PO postoperative, IMV invasive mechanical ventilation

aAccording to West Haven classification